Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB (Q37194280)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2009
edit
Language Label Description Also known as
English
Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB
scientific article published on January 2009

    Statements

    Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB (English)
    Peter T Nelson
    Richard J Kryscio
    Erin L Abner
    Frederick A Schmitt
    Gregory A Jicha
    Marta S Mendiondo
    Greg Cooper
    Charles B Smith
    William R Markesbery
    1 January 2009
    29-34

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit